StageZero Life Sciences Investor Relations Material
Latest events
Q1 2024
StageZero Life Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from StageZero Life Sciences Ltd
Access all reports
StageZero Life Sciences Ltd. specializes in providing molecular diagnostic solutions, leveraging a telehealth program that employs advanced diagnostics for the early detection of cancer and chronic diseases. The company is known for developing blood-based biomarker tests, particularly for identifying colorectal cancer. A key innovation from StageZero is its Sentinel Principle technology, which is instrumental in early disease diagnosis, staging, response identification, and treatment monitoring. Additionally, StageZero offers Aristotle, an mRNA-based test capable of detecting multiple cancers from a single blood sample. StageZero Life Sciences is headquartered in Richmond Hill, Ontario, and its shares are listed on the Toronto Stock Exchange.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
SZLS
Country
🇨🇦 Canada